Monoclonal antibodies have been used to show that an epitope is present on the G1 glycoprotein of prototype La Crosse virus that is absent or significantly altered on several isolates of La Crosse virus made in New York State, U.S.A. The portion of the G1 protein where this epitope is located plays a role in both virus neutralization and haemagglutination. Additional experiments revealed that under the appropriate assay conditions the monoclonal antibodies permitted discrimination between representatives of the North American members of the California serogroup.
INTRODUCTION
The California encephalitis (CE) complex of the California (CAL) serogroup, genus Bunyavirus, family Bunyaviridae, consists of a set of viruses which are closely related serologically and which have a broad geographic distribution. Three virus types are currently recognized within the CE complex: California encephalitis, Melao and trivittatus (Bishop & Shope, 1979; Calisher, 1983) . Several of these viruses are known to infect humans, producing ailments ranging from encephalitis and meningitis to more mild, non-neurologic illnesses (for review, see LeDuc, 1979) .
At the molecular level, the genomes of these viruses have been shown to consist of negativestranded RNA which occurs in three segments of distinct sizes (Obijeski et al., 1976a) . The middle-size segment codes for the large and small virion glycopeptides (G1 and G2, respectively) and the small RNA encodes the nucleocapsid (N) protein and a non-structural protein (Gentsch & Bishop, 1978 , 1979 Clerx-van Haaster et al., 1982) . Although the assignment is still uncertain, the large RNA is likely to code for the large (L) protein found as a minor component in the virion.
With respect to the genome, the technique of RNase TI fingerprinting has been used to great advantage to study many of the CAL viruses (Clewley et al., 1977; E1 Said et al., 1979; Klimas et al., 1981) . Much of this work has focused on La Crosse (LAC) virus and has revealed that no two isolates of LAC exhibit identical fingerprints. It was also found that the oligonucleotide patterns obtained with LAC isolates from New York State, U.S.A. were sufficiently distinct from those of the prototype strain (isolated in Wisconsin) that it was suggested that the New York isolates be considered 'varieties' of LAC (El Said et al., 1979) . On the other hand, New York isolates cannot be consistently differentiated serologically from other LAC isolates and thus the question arises as to the extent to which differences observed in the fingerprints are reflected in the antigenic properties of the virions. In our laboratory, it was decided to approach this question through the use of monoclonal'antibodies. The present communication describes the properties of the antibodies we have obtained so far and provides evidence that at least one epitope on the GI protein of prototype LAC is either significantly altered or missing in several independent isolates made in New York. Data are also presented which demonstrate that monoclonal antibodies without neutralizing and haemagglutination-inhibiting activity are still useful in discriminating among CAL viruses by enzyme-linked immunosorbent assay (ELISA). 
METHODS

Viruses.
The viruses used and their passage histories are given in Table 1 . New York isolates of LAC were identified by complement fixation and neutralization (Grayson et al., 1983) . Viruses were grown and plaquepurified on BHK-21 cells using the Glasgow modification (MacPherson & Stoker, 1962 ) of Eagle's medium plus 10~ foetal bovine serum (FBS). Virus purification was carried out as detailed by Obijeski et al. (1976b) and consisted of precipitation of virus from the culture supernatant with polyethylene glycol (PEG) followed by banding first in a potassium tartrate-glycerol gradient and then in a linear 35 to 70~ sucrose gradient. Only material having the density of whole virions (1-2 g/ml in the former, and 1.17 to 1-19 g/ml in the latter gradient) was collected.
Monoclonal antibody production. Prototype LAC virus was inactivated with 0.2 ~ fl-propiolactone. Viral protein was determined by a modified Lowry method (Peterson, 1977) . BALB/c mice were inoculated intraperitoneally with 100 ktg of total LAC protein emulsified in complete Freund's adjuvant. A second inoculation, exactly as above, was given 1 month later. After an additional 2 weeks 100 ~tg of LAC protein was given intravenously and 3 days later a mouse was sacrificed, the spleen removed into RPMI 1640 medium (without serum) and dissociated. The spleen cells were combined with myeloma cells (the non-producing clone X63-Ag8.653 of the P3-X63-Ag cell line; Kearney et al., 1979) at a ratio of 5 : 1, and the cells were pelleted by centrifugation. Fusion was carried out by adding, with gentle stirring, 1 ml of 50~ PEG (Sigma, 1000) in RPMI 1640 over a period of 1 rain. The mixture was held at 37 °C for 1.5 min, and then the PEG was slowly diluted out by adding, with gentle stirring over a period of 5 min, 20 ml of RPMI 1640. The cells were collected by centrifugation and gradually brought to a final volume of 80ml with RPMI 1640 containing 15% FBS and hypoxanthine, aminopterin and thymidine (10-4M, 4 x 10 -7 M, and 1.6 × 10 -5 M, respectively). The cells were distributed into the wells of eight 96-well dishes (Costar) and placed in a humidified, 5% CO2 incubator at 37 °C. Each well of these dishes had been seeded 24 h previouslywithafeederlayerof5 x 10~ mouse peritoneal exudate cells. Visible clones arose over the next several weeks, and 50 ~tl of each supernatant was tested by ELISA (see below) for antibody to prototype LAC virus. The cells from wells that scored positive were cloned twice by limiting dilution and those that continued to score positive were finally grown in mass culture, and aliquots were stored in liquid nitrogen. To obtain large amounts of the monoclonal antibodies, the hybridomas were grown in ascites form in pristane-primed BALB/c mice. Monoclonal antibodies were purified from ascitic fluid by binding to Protein A-Sepharose (Pharmacia) followed by pH elution as described by Ey et al. (1978) . The final protein concentration was determined from the A zs o using an extinction coefficient of 14 for a 1 ~ (w/v) solution and a 1 cm path length.
Immunoglobulin class. The immunoglobulin class and the light-chain characteristics of the monoclonal antibodies were determinated by ELISA using specific antibodies supplied in the Mouo Ab-ID kit from Zymed Laboratories.
Separation ofviralproteins. Purified preparations of prototype LAC virus were disrupted with 2~ Triton X-100 in the presence of 0-5 M-NaC1 (Obijeski et al., 1976b) . To separate the nucleocapsid and glycoprotein fractions, 1.0 ml of the disrupted virions was layered over 4.0 ml of 30~ sucrose in Dulbecco's phosphate-buffered saline (PBS), then centrifuged for 16 h at 38000 rev/min in a SW50.1 rotor (Beckman Instruments). The top 1.5 ml, containing the glycoproteins, was carefully removed with a Pasteur pipette. The remainder of the sucrose solution was taken off and the nucleocapsid pellet resuspended in PBS. The G1 and G2 glycoproteins were further fractionated by passage over a column (1 × 50 cm) of Sephadex G-200 (Pharmacia) in PBS. The Gt protein (approx. tool. wt. 115 000) eluted at the void volume of the column, and the G2 protein (approx. mol. wt. 38 000) eluted behind bovine serum albumin, which had been added as a marker. Both glycoprotein fractions, as well as the nucleocapsids, were antigenically active when tested with anti-LAC mouse serum. Such protein fractions were used in the solid phase of an ELISA to determine the specificity of the monoclonal antibodies.
Antigens and serological tests. Haemagglutinating (HA) antigens for each of the CAL virus subtypes were prepared by double acetone extraction of fluids from infected cell cultures (S. Srihongse, unpublished data). These HA antigens were specifically inhibited by homologous immune mouse sera. The sera were obtained by injecting 3-month-old female mice with two doses of virus, each equivalent to 104 LDso. The inocula were given intraperitoneally a week apart and the mice were bled 14 days after the second dose. In the haemagglutination inhibition (HI) test (Clarke & Casals, 1958) , antigen-antibody mixtures in microtitre plates were held overnight at 4 °C and then goose erythrocytes were added. Tests were performed with 4 units of antigens. Neutralization tests were carried out using BHK-21 cells by the plaque-reduction method of Lindsey et al. (1976) .
ELISA. In all assays, purified preparations of the appropriate virus were diluted with PBS to 10 ktg/ml of viral protein. Aliquots of 25 til were dispensed to as many wells as necessary of a flexible, polyvinyl test plate (Dynatech) and evaporated to dryness at 37 °C. The plate was then treated with absolute methanol for 5 min at room temperature and dried. Antibodies were diluted as indicated with PBS plus 0.1 ~o Tween 20 (PBST), and 50 ~tl was added to the appropriate wells, after which the plate was covered with Parafilm and incubated for 3 h at 37 °C. This was followed by 10 washes with PBST. Next, Bethesda Research Laboratories' hybridoma screening reagent [fl-galactosidase from Escherichia coli, conjugated to F(ab')2 fragments of sheep anti-mouse IgG] was diluted 200-fold in PBST, and 50 I.tl was added to each well. The plate was again covered and incubated for 2 h at room temperature with gentle shaking. After another series of 10 washes with PBST, each well received 50 ~tl of substrate (p-nitrophenyl-fl-D-galactoside, 1.0 mg/ml), and the plate was covered and incubated for 1 h at room temperature with gentle shaking. The reaction was stopped by adding 50 i.tl of 0-5 M-Na2CO3 per well. Plates were read with a Dynatech 590 reader.
RESULTS
General characteristics
Seven hybridomas were obtained from a fusion in which the splenic donor mouse had been immunized with prototype LAC virus. Six of these have been successfully grown in ascites form in pristane-primed BALB/c mice and purified from ascitic fluid as described in Methods. In every case, more than 90~ of the material absorbing at 280 nm that was recovered from the column was in the fraction expected for IgG2a. This tentative identification of the subclass to which the monoclonal antibodies belonged was later confirmed by ELISA using specific rabbit anti-mouse immunoglobulins. Specific antibodies were also used to show that all of the monoclonal antibodies had kappa light chains.
To determine which viral proteins carried the epitopes for the monoclonal antibodies, a fresh preparation of purified LAC virus was disrupted and the proteins separated as described in Methods. The viral proteins were then used in the solid phase of an ELISA and it was found that all of the monoclonal antibodies were specific for the G1 glycoprotein of LAC.
Haemagglutination inhibition
The results of HI tests with the six monoclonal antibodies and at least one'representative of each North American subtype of the CE complex are summarized in Table 2 . Four of the antibodies were found to inhibit haemagglutination. The activity of one of these, 3G8, was restricted to prototype LAC and that of another, 7B 11, was limited to LAC isolates. The finding with 3G8 suggests that its epitope is missing or modified with respect to the New York variety of LAC and to the best of our knowledge represents the first demonstration of a difference between LAC isolates at a specific antigenic site.
The remaining two antibodies, 5D4 and 2B9, were positive in HI tests with a broad spectrum of CE complex viruses, the latter being active with all of the viruses tested. * Titres are for 90~ or more reduction. A 10-fold dilution was the lowest employed; hence -= < 10. ~Initial antibody concentrations were approximately 1.0 mg/ml. t,:~, §,ll Same as Table 2 .
With this particular panel of monoclonal antibodies, it was not possible to distinguish among all of the CE complex viruses on the basis of HI. However, discrimination between prototype and New York LAC, as well as between LAC and its SSH variety was possible.
Neutralization
Plaque-reduction neutralization assays revealed that three of the monoclonal antibodies possess neutralizing activity (Table 3 ). The most marked difference between these results and those obtained for HI occurred with antibody 2B9. This antibody was positive by HI and negative by neutralization with all of the viruses examined. In other respects the two assays were in close agreement. Once again, only prototype LAC responded with antibody 3G8, thus strengthening the conclusion that its epitope is absent from the other viruses studied.
ELISA
The reaction patterns of the monoclonal antibodies in an ELISA which employed gradientpurified viruses as the solid phase are presented in Table 4 . Although the data shown were obtained using 30 ng/well of antibody, no changes were observed when the antibody level was increased to 120 ng/well. All of the antibodies reacted with prototype LAC, as expected since ELISA was used during the development stage to select antibody-secreting clones. Where comparisons were possible, the ELISA results were in agreement with those yielded by HI and neutralization. Accordingly, all three assays were consistent in suggesting that the epitope for antibody 3G8 is either absent or altered with respect to the G~ glycoprotein of New York LA-C 74-32813. In the case of the ELISA, this conclusion can be seen to apply to a second, Table 2. independent New York isolate (76-33795) as well. Furthermore, it should be noted that 3G8 behaved similarly when the supernatants of cell cultures infected with non-plaque-purified samples of prototype LAC, 74-32813, and two additional independent New York isolates were examined (data not shown). Two antibodies reacted in the ELISA which were negative for both neutralization and HI: 1A7 and 5D2. Consequently, the ELISA results with the monoclonal antibodies were the most complex and showed a distinct pattern with each of the North American subtypes of the CE complex. This demonstrates that monoclonal antibodies that lack activity in the commonly employed HI and neutralization tests may still be useful for discriminating among viruses.
DISCUSSION
The experiments which have been described show that at least one epitope, located at a site on the viral G, glycoprotein that is involved with both neutralization and haemagglutination, differs between prototype LAC virus, which was isolated in Wisconsin from a patient with encephalitis (Thompson et al., 1965) and several separate mosquito isolates from New York State. The identity of the LAC viruses used in these experiments was verified by demonstrating that RNase T t fingerprints of their genomes (data not shown) corresponded to those reported by E1 Said et aL (1979) for prototype LAC and the New York variety. The ability to discriminate LAC isolates in this way suggests that monoclonal antibodies may be useful in assessing whether particular antigenic varieties of LAC occur in areas with the highest rates of clinical illness. This could be of considerable value because direct isolation of LAC from patients is very rare (Thompson et al., 1965; Klimas et aL, 1981) .
With all of the CE complex viruses studied, wherever comparisons were permitted there was good agreement between the HI, neutralization, and ELISA results with the monoclonal antibodies. At the same time, with this particular group of antibodies the discriminatory ability of both of the former tests was limited to differentiating between varieties of the same subtype, as they gave distinct patterns only for prototype and New York LAC, and, in the case of HI, for the SSH variety of LAC. In the ELISA, however, the additional contributions of the two antibodies that were inactive in the other assays, 1A7 and 5D2, made it possible to distinguish among all of the subtypes examined. These included at least one example of each of the North American members of the CE complex, which number among them representatives of all three of the currently recognized virus types. This illustrates that such antibodies can provide information concerning the antigenic differences among closely related viruses that cannot rapidly and economically be obtained by other procedures.
While this work was in progress, another report on monoclonal antibodies to CE complex viruses by Gonzalez-Scarano et al. (1982) was published. These investigators, too, found that such antibodies were useful in discriminating among the members of this group of viruses. Our
